Healthcare >> CEO Interviews >> September 6, 2013
Thomas W. Gardner has been the President, CEO and Director of AtheroNova Inc. since the May 2010 reverse merger. He held the same positions with Z&Z Medical Holdings, Inc., a Nevada corporation and the predecessor in interest to AtheroNova Operations (Z&Z Nevada) from December 2006 until its merger into AtheroNova Operations in March 2010. Since September 2008, he also has been the President of PhyGen LLC, which designs, manufactures and sells instruments and implants for spine surgery. He has extensive experience with successful startup ventures, having helped found six health care companies, of which three were publicly traded. Profile
Mr. Gardner: The company was founded in 2006 by two physicians who had witnessed a natural disease state
